Fantini, J., Azzaz, F., Aulas, A., Chahinian, H., & Yahi, N. Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53. Nature Portfolio.
Chicago Style (17th ed.) CitationFantini, Jacques, Fodil Azzaz, Anaïs Aulas, Henri Chahinian, and Nouara Yahi. Correction: Preclinical Assessment of a Ganglioside-targeted Therapy for Parkinson’s Disease with the First-in-class Adaptive Peptide AmyP53. Nature Portfolio.
MLA (9th ed.) CitationFantini, Jacques, et al. Correction: Preclinical Assessment of a Ganglioside-targeted Therapy for Parkinson’s Disease with the First-in-class Adaptive Peptide AmyP53. Nature Portfolio.
Warning: These citations may not always be 100% accurate.